Ablain, Julien <br/><br/>
Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.  [electronic resource] 

 -  Nature medicine  Feb 2014 
 - 167-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/nm.3441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Computational Biology<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Mice<br/>Microarray Analysis<br/>Nuclear Proteins--metabolism<br/>Oxides--pharmacology<br/>Promyelocytic Leukemia Protein<br/>Proteolysis--drug effects<br/>Receptors, Retinoic Acid--metabolism<br/>Recombinant Fusion Proteins--metabolism<br/>Retinoic Acid Receptor alpha<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--physiology<br/>Transcription Factors--metabolism<br/>Tretinoin--pharmacology<br/>Tumor Suppressor Protein p53--metabolism<br/>Tumor Suppressor Proteins--metabolism